Turner Investments’s Pfizer PFE Stock Holding History

Turner Investments’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-191,090	Closed	-$195K	–	655
2013 Q2	$195K	Buy	+191,090	New	+$5.28M	﹤0.01%	595

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Turner Investments's PFE Position: Q2 2017 in Review

Turner Investments sold out of Pfizer (PFE) in Q2 2017, closing a stake of 5,238 shares — an estimated $170K sold.

Turner Investments first reported a position in PFE in Q3 2013 and held it in 10 quarters. The position peaked at $9.17M in Q3 2013. 2,049 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

Turner Investments reported no remaining Pfizer position as of Q2 2017 after selling out during the quarter.
Turner Investments sold 5,238 Pfizer shares in Q2 2017, an estimated $170K.
Turner Investments first reported a position in Pfizer in Q3 2013 and held it in 10 quarters.
Turner Investments's Pfizer position peaked at $9.17M in Q3 2013.
2,049 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on Turner Investments's 13F filing for Q2 2017, filed 4 Aug 2017.